Maven Capital Partners

Activity from announced rounds

Activity in this selectionOct 24, 2026 · Healthtech · Jan 1, 2026
Rounds participated in
2
Confirmed lead rounds
—
2 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$23.6M
2 disclosed · full round size, not this investor’s share

By stage

Series A1
Undisclosed1

By primary sector

Biotech1
Healthtech1

By country

United Kingdom2

Rounds

2 in this selection
Biocaptiva

Develops liquid biopsy technology for early cancer detection

£15.8MSeries A
Role not disclosed
Nami Surgical

Develops high-performance miniaturised ultrasonic scalpels for robotic-assisted surgery

£1.9MUndisclosed
Role not disclosed